Searched for
GRANULES INDIA SHARES
JSW Cement Q4 Results: Co reports profit of Rs 362 crore, declares Rs 0.5 dividendJSW Cement reported a sharp jump in March-quarter earnings, driven by higher sales volumes and improved operational efficiencies. The compa...
For investors with long-term perspective: 5 mid-cap stocks from different sectors with upside potential of up to 30%Even before the US-Israel-Iran war began, there was a sort of readjustment taking place in the mid-cap segment – a kind of valuation readju...
Ahead of Market: 10 things that will decide stock market action on TuesdayThe Nifty 50 and BSE Sensex rebounded on broad-based buying led by pharma, IT, auto and metals. Volatility eased, while analysts signalled ...
Correction may be opportunity for some: 5 mid-cap stocks from different sectors with an upside potential up to 28%Will they? Won’t they? Even as uncertainty persists over the proposed second round talks between the US and Iran, markets across the globe ...
Ahead of Market: 10 things that will decide stock market action on ThursdayThe Nifty 50 and BSE Sensex surged over 1.6% after US–Iran talks optimism boosted sentiment, driving broad-based buying. Falling volatility...
Stocks in news: RIL, TCS, IDFC First Bank, BPCL, SpiceJetIndian equity markets saw profit booking on April 9, ending a five-day rally. Several companies like RIL, TCS, and IDFC First Bank are in f...
Ahead of Market: 10 things that will decide stock market action on ThursdayTrump’s two-week ceasefire announcement boosted Nifty and global markets, with strong gains across banking, auto, and energy sectors. Techn...
Ahead of Market: 10 things that will decide stock market action on TuesdayIndian markets rallied for a third straight session, led by banks, auto, and consumer stocks. Nifty crossed 22,900 while Sensex surged shar...
Granules India shares in focus after US FDA flags observation at Telangana API facilityThe US FDA issued a Form 483 observation for its Telangana API facility. While not a final non-compliance verdict, the company plans a time...
Buy Granules India, target price Rs 625: Motilal Oswal SecuritiesMotilal Oswal Securities has recommended buying shares of Granules India Ltd. with a target price of Rs 625. Currently priced at Rs 535.45,...
Granules India shares tank 16% after USFDA issues 6 observationsGranules India’s shares plummeted 16% to Rs 566 on Thursday after receiving six observations from the USFDA, including issues with equipmen...
Technical Stock Pick: 20% rally in 3 months! This pharma stock breaks out from a rounding bottom pattern; time to buy?Short-term traders can look to buy the stock now for a target of Rs 590 in the next 3 months, suggest experts.
Stock Radar: Up 50% in 6 months! Why Granules India could keep hitting record highs: Ajit MishraThe pharma stock rose from Rs 291 on August 14 to Rs 435 recorded on February 15, which translates into an upside of about 50% in six month...
Granules India rallies 6% as PI Industries looks to buy promoter stakeGranules is a large-scale vertically integrated company that manufactures API, intermediates and finished dosages and has seven manufacturi...
Granules India Q1 results: Net profit up 8% to Rs 120 croreConsolidated revenue from operations of the company stood at Rs 850 crore for the quarter under consideration. It was Rs 736 crore for the ...
Present tense, future perfect for this pharma multibagger; grab it if you have the patienceAnalysts acknowledge the supply-side challenges and the burden of rising raw material costs in the near term.
Buy Granules India, target Rs 130: Motilal OswalBuy Granules India Ltd. at a price target of Rs 130.